Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.7 HKD | -1.55% | -0.18% | -15.30% |
Apr. 25 | Simcere Pharmaceutical’ Profit Down 23% in 2023 | MT |
Apr. 10 | Simcere Pharmaceutical's Cancer Drug Gets Fast Track Designation From US FDA | MT |
Chart calendar Simcere Pharmaceutical Group Limited
Upcoming events on Simcere Pharmaceutical Group Limited
No events available
Past events on Simcere Pharmaceutical Group Limited
2023-04-19 09:00 am | American Association for Cancer Research Meeting - Abstract Number: 6201 |
2023-04-19 09:00 am | American Association for Cancer Research Meeting - Abstract Number: 6357 |
2023-04-17 02:30 pm | American Association for Cancer Research Meeting - Abstract Number: 3474 |
2023-04-17 09:00 am | American Association for Cancer Research Meeting - Abstract Number: 1883 |
2023-04-17 09:00 am | American Association for Cancer Research Meeting - Abstract Number: 1882 |
2023-04-17 09:00 am | American Association for Cancer Research Meeting - Abstract Number: 1724 |
2023-04-16 03:00 pm | American Association for Cancer Research Meeting - Abstract Number: 1137 |
2023-04-16 01:30 pm | American Association for Cancer Research Meeting - Abstract Number: 512 |
2023-03-30 | Q4 2022 Earnings Release |
Past dividends on Simcere Pharmaceutical Group Limited
2023-06-18 | Annual 0.17576 HKD |
2022-06-27 | Annual 0.1757 HKD |
2021-06-28 | Annual 0.18031 HKD |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 747 | 689 707 -2.63% | 785 816 -3.77% | 920 931 -1.18% | 918 946 -2.92% | 1 033 |
EBITDA Million USD | Released Forecast Spread | 0,00 | 108 137 -21.37% | 267 209 27.73% | 158 128 23.13% | 131 181 -27.43% | 189 |
EBIT Million USD | Released Forecast Spread | 0,00 | 74,1 112 -33.86% | 178 195 -8.5% | 126 87,7 43.2% | 98,9 161 -38.68% | 140 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 123 110 12.12% | 220 277 -20.62% | 129 99,9 29.38% | 103 218 -52.94% | 144 |
Net income Million USD | Released Forecast Spread | 149 | 102 94,5 8.28% | 237 239 -0.96% | 136 95,1 42.81% | 99,3 98,5 0.82% | 141 |
EPS CNY | Released Forecast Spread | 0,00 | 0,28 0,24 19.15% | 0,58 0,58 0% | 0,36 0,28 27.96% | 0,27 0,27 1.86% | 0,39 |
Announcement Date | 12/10/20 | 25/03/21 | 24/03/22 | 31/03/23 | 20/03/24 | - |
Quarterly results
Fiscal Period | December | 2023 S1 | 2023 S2 |
---|---|---|---|
Net sales Million USD | Released Forecast Spread | 448 468 -4.18% | |
Net income Million USD | Released Forecast Spread | 313 | |
EPS CNY | Released Forecast Spread | 0,86 | |
Announcement Date | 21/08/23 | 20/03/24 |
Past sector events for Simcere Pharmaceutical Group Limited
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 2096 Stock
- Calendar Simcere Pharmaceutical Group Limited